Gordon Sussman Clinical Research

Toronto, Ontario M4V 1R2

0 studies enrolling now · 8 studies all time

What they study most

Hereditary Angioedema, Immunologic Deficiency Syndromes, Peanut Allergy, Urticaria

Studies at this site

• Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks — Completed
• Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) — Completed
• Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency — Completed
• Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children — Completed
• AR101 Real-World Open-Label Extension Study — Completed
• Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) — Completed
• Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy — Completed
• A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU). — Completed